Holding(s) in Company
19 April 2021
("Instem" or "the Company")
Holding(s) in Company
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that on 16 April 2021, DWT Holdings, Inc (“DWTH”) notified the Company of its interest in 868,203 ordinary shares of ten pence each in the capital of the Company (the “Ordinary Shares”), representing 3.99 per cent. of the Company’s total voting rights.
As previously announced, the Ordinary Shares were issued to DWTH as part of the consideration for the acquisition of d-Wise Technologies, Inc (“d-Wise”) which legally completed on 1 April 2021, with the Ordinary Shares being admitted to trading on AIM on 14 April 2021. DWTH will, in due course, transfer these Ordinary Shares to the two d-wise founding shareholders and 16 further employees.
Download the notification of major holdings (TR1):
For further information, please contact:
|Instem plc||Via Walbrook|
|Phil Reason, CEO|
|Nigel Goldsmith, CFO|
|N+1 Singer (Nominated Adviser & Broker)||+44 (0) 20 7496 3000|
|Peter Steel / Alex Bond|
|Wallbrook Financial PR||Tel: +44 (0) 20 7933 8780|
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by over 600 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.
To learn more about Instem solutions and its mission, please visit instem.com.